VFA
TEVA icon

Voya Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Voya Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,628
Closed -$250K – 553
2017
Q2 		$250K Buy
7,628
+885
+13% +$27.4K 0.02% 421
2017
Q1 		$223K Sell
6,743
-342
-5% -$11.7K 0.02% 439
2016
Q4 		$256K Buy
7,085
+547
+8% +$21.8K 0.02% 392
2016
Q3 		$303K Buy
6,538
+1,505
+30% +$78.5K 0.03% 328
2016
Q2 		$253K Buy
+5,033
New +$268K 0.03% 338
2016
Q1 		– Sell
-3,438
Closed -$227K – 407
2015
Q4 		$227K Buy
+3,438
New +$212K 0.03% 316

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Voya Financial Advisors's TEVA Position: Q3 2017 in Review

Voya Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 7,628 shares — an estimated $250K sold.

Voya Financial Advisors first reported a position in TEVA in Q4 2015 and held it in 6 quarters. The position peaked at $303K in Q3 2016. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Voya Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Voya Financial Advisors sold 7,628 Teva Pharmaceuticals shares in Q3 2017, an estimated $250K.
  • Voya Financial Advisors first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 6 quarters.
  • Voya Financial Advisors's Teva Pharmaceuticals position peaked at $303K in Q3 2016.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Voya Financial Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.